Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Bay JO, André T, Caux C, Evrard S, Gonçalves A, L’Allemain G, Magné N, Orbach D, Penel N, Rodrigues M, Thariat J, Thiery-Vuillemin A, Wislez M. Retours sur quelques importantes avancées en oncologie et hématologie de 2018 : une sélection du comité de rédaction du Bulletin du Cancer. Bull Cancer 2019;106:12-23. [DOI: 10.1016/j.bulcan.2018.12.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

For:	Bay JO, André T, Caux C, Evrard S, Gonçalves A, L’Allemain G, Magné N, Orbach D, Penel N, Rodrigues M, Thariat J, Thiery-Vuillemin A, Wislez M. Retours sur quelques importantes avancées en oncologie et hématologie de 2018 : une sélection du comité de rédaction du Bulletin du Cancer. Bull Cancer 2019;106:12-23. [DOI: 10.1016/j.bulcan.2018.12.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]

Number

Cited by Other Article(s)

Thiery-Vuillemin A. [Updates in onco-urology: academic research is a key factor]. Bull Cancer 2020;107:S2-S4. [PMID: 32620203 DOI: 10.1016/s0007-4551(20)30271-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]

Rodrigues M. [PARP inhibitors in first-line of ovarian cancers]. Bull Cancer 2020;107:4-5. [PMID: 31928735 DOI: 10.1016/j.bulcan.2019.10.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2019] [Accepted: 10/24/2019] [Indexed: 11/28/2022]

Vignot S, Chapel E. [New prescription procedures for authorisations for temporary use: A key step for access to innovation]. Bull Cancer 2019;106:943-945. [PMID: 31563270 DOI: 10.1016/j.bulcan.2019.07.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Revised: 07/12/2019] [Accepted: 07/19/2019] [Indexed: 10/25/2022]